Scientists from Massachusetts Eye and Ear/Harvard Medical School Department of Ophthalmology have used the power of new genomic technology to discover that microbes that commonly infect the eye have special, previously unknown properties. These properties are predicted to allow the bacterium -- Streptococcus pneumoniae -- to specifically stick to the surface of the eye, grow, and cause damage and inflammation.
Researchers are now using this information to develop new ways to treat and prevent this bacterium, which is becoming increasingly resistant to antibiotics. Their findings are in the current issue of Nature Communications.
S. pneumoniae is a leading cause of infection and is responsible for diseases ranging from infection of the lungs, pneumonia, to infection of the brain, to infection of the surface of the eye known as conjunctivitis. Although infection of the eye can usually be safely treated, S. pneumoniae infection is a leading cause of illness and death worldwide.
According to Mass. Eye and Ear researcher Michael S. Gilmore, Sir William Osler Professor of Ophthalmology, Harvard Medical School, an effective vaccine is available that helps prevent many of the most severe types of infection. "I believe it is especially important for children and the elderly to be vaccinated. The vaccine causes the body to react to a slimy coating on the bacterial surface called a "capsule." The capsule allows S. pneumoniae to escape from white blood cells that try to eliminate it, and S. pneumoniae goes on to cause lung and other infections."
However, the strains of S. pneumoniae that cause eye infection have been known to lack this capsule, yet they still cause infection. "Because they lack the capsule, they are not affected by the vaccine either," he continued.
To design a better vaccine, and to understand how these "unencapsulated" strains of S. pneumoniae are still able to cause infection of the ocular surface, the research team, spearheaded by postdoctoral researcher Michael Valentino and including Mass. Eye and Ear scientists Wolfgang Haas and Paulo Bispo, as well as a collaborative team from the Broad Institute of Harvard University and Massachusetts Institute of Technology, the U.S. Centers for Disease Control and Prevention, and elsewhere, examined the genomes of a large collection of S. pneumoniae strains collected from across the United States.
"We found that about 90 percent of the conjunctivitis strains were very closely related and formed a new group of S. pneumoniae with infectious properties that were different from any other known strains," Dr. Gilmore said. "These new properties are believed to allow S. pneumoniae to resist the normal clearance mechanisms of the surface of the eye, including blinking and tears, stick to the eye surface, grow there and cause damage."
Dr. Gilmore believes that including some of the S. pneumoniae proteins that allow the bacterium to do this in a new type of vaccine, might lead to the prevention of nearly 90 percent of the cases of conjunctivitis caused by this microbe and save the use of antibiotics for more severe infections.
The paper, entitled "Unencapsulated Streptococcus pneumoniae from conjunctivitis encode variant traits and belong to a distinct phylogenetic cluster," appears in the Nov. 13 issue of issue of the prestigious international science journal, Nature Communications.
Portions of this project were supported by NIH grants EY024285, Molecular Basis for Ocular Surface Tropism in Conjunctivitis and by the Harvard-wide Program on Antibiotic Resistance, AI083214. HHSN272200900018C supported the involvement of A.M.M. Additional support for this project was obtained from the ALSAC organization of St Jude Children's Research Hospital (J.W.R., C.B., R.A.C. and E.I.T.). In addition, portions of this project were supported by Bausch and Lomb Inc. (C.M.S., W.H., T.W.M. and M.S.G.). M.D.V. was supported in part by NIH fellowship through EY007145.
About Massachusetts Eye and Ear
Massachusetts Eye and Ear clinicians and scientists are driven by a mission to find cures for blindness, deafness and diseases of the head and neck. Led by the Howe Laboratory in Ophthalmology, Schepens Eye Research Institute, and the Eaton-Peabody Laboratory in Otology, Mass. Eye and Ear in Boston is the world's largest vision and hearing research center, offering hope and healing to patients everywhere through discovery and innovation.
Mass. Eye and Ear is a Harvard Medical School teaching hospital that trains future medical leaders in ophthalmology and otolaryngology, through residency as well as clinical and research fellowships. Internationally acclaimed since its founding in 1824, Mass. Eye and Ear employs full-time, board-certified physicians who offer high-quality and affordable specialty care that ranges from the routine to the very complex. U.S. News & World Report's "Best Hospitals Survey" has consistently ranked the Mass. Eye and Ear Departments of Ophthalmology and Otolaryngology as among the best in the nation.
Mary Leach | EurekAlert!
TSRI researchers develop new method to 'fingerprint' HIV
29.03.2017 | Scripps Research Institute
Periodic ventilation keeps more pollen out than tilted-open windows
29.03.2017 | Technische Universität München
The Institute of Semiconductor Technology and the Institute of Physical and Theoretical Chemistry, both members of the Laboratory for Emerging Nanometrology (LENA), at Technische Universität Braunschweig are partners in a new European research project entitled ChipScope, which aims to develop a completely new and extremely small optical microscope capable of observing the interior of living cells in real time. A consortium of 7 partners from 5 countries will tackle this issue with very ambitious objectives during a four-year research program.
To demonstrate the usefulness of this new scientific tool, at the end of the project the developed chip-sized microscope will be used to observe in real-time...
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
20.03.2017 | Event News
14.03.2017 | Event News
07.03.2017 | Event News
29.03.2017 | Materials Sciences
29.03.2017 | Physics and Astronomy
29.03.2017 | Earth Sciences